CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L107. A total of 2 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bracebridge Capital, LLC | 2,002,495 | $761,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 200,000 | $76,000 | 0.05% |
| Ayrton Capital LLC | 32,525 | $12,000 | 0.02% |
| Powell Investment Advisors, LLC | 60,000 | $23,000 | 0.01% |
| Virtu Financial LLC | 188,086 | $72,000 | 0.01% |
| Warberg Asset Management LLC | 55,000 | $21,000 | 0.01% |
| UBS Group AG | 23,534 | $9,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 45,000 | $17,000 | 0.00% |
| Squarepoint Ops LLC | 29,085 | $11,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 10,001 | $4,000 | 0.00% |